Alaunos Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Alaunos Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Alaunos Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 33.5 %, a 53.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 33.5 -37.9 -53.1% Jun 30, 2024
Q1 2024 32.2 -49.4 -60.5% Mar 31, 2024
Q4 2023 46.1 -35.9 -43.8% Dec 31, 2023
Q3 2023 55.3 -23.6 -29.9% Sep 30, 2023
Q2 2023 71.4 +1.32 +1.88% Jun 30, 2023
Q1 2023 81.6 +30 +58.2% Mar 31, 2023
Q4 2022 82 +43.6 +114% Dec 31, 2022
Q3 2022 78.9 +50.8 +181% Sep 30, 2022
Q2 2022 70.1 +51.8 +283% Jun 30, 2022
Q1 2022 51.6 +35.9 +229% Mar 31, 2022
Q4 2021 38.4 +25.4 +196% Dec 31, 2021
Q3 2021 28.1 +15.9 +130% Sep 30, 2021
Q2 2021 18.3 +6.89 +60.4% Jun 30, 2021
Q1 2021 15.7 +3.28 +26.4% Mar 31, 2021
Q4 2020 13 -0.77 -5.6% Dec 31, 2020
Q3 2020 12.2 -0.53 -4.16% Sep 30, 2020
Q2 2020 11.4 -130 -92% Jun 30, 2020
Q1 2020 12.4 +117 Mar 31, 2020
Q4 2019 13.8 +72.3 Dec 31, 2019
Q3 2019 12.7 +60.1 Sep 30, 2019
Q2 2019 142 +196 Jun 30, 2019
Q1 2019 -105 -40.8 -63.4% Mar 31, 2019
Q4 2018 -58.5 +10.7 +15.5% Dec 31, 2018
Q3 2018 -47.3 +26.2 +35.6% Sep 30, 2018
Q2 2018 -54.3 +23.7 +30.4% Jun 30, 2018
Q1 2018 -64.3 +59.7 +48.2% Mar 31, 2018
Q4 2017 -69.3 +243 +77.8% Dec 31, 2017
Q3 2017 -73.5 -832 -110% Sep 30, 2017
Q2 2017 -78.1 -266 -141% Jun 30, 2017
Q1 2017 -124 -185 -305% Mar 31, 2017
Q4 2016 -312 -354 -855% Dec 31, 2016
Q3 2016 758 +726 +2254% Sep 30, 2016
Q2 2016 188 +172 +1066% Jun 30, 2016
Q1 2016 60.5 +37.4 +162% Mar 31, 2016
Q4 2015 41.4 -0.87 -2.06% Dec 31, 2015
Q3 2015 32.2 -12.7 -28.3% Sep 30, 2015
Q2 2015 16.2 -49.9 -75.5% Jun 30, 2015
Q1 2015 23.1 -61.2 -72.6% Mar 31, 2015
Q4 2014 42.2 -48.4 -53.4% Dec 31, 2014
Q3 2014 44.9 -58.1 -56.4% Sep 30, 2014
Q2 2014 66 -14.9 -18.4% Jun 30, 2014
Q1 2014 84.2 +14.7 +21.1% Mar 31, 2014
Q4 2013 90.7 +29.6 +48.5% Dec 31, 2013
Q3 2013 103 +46 +80.9% Sep 30, 2013
Q2 2013 80.9 +30.9 +61.8% Jun 30, 2013
Q1 2013 69.6 +20.2 +41% Mar 31, 2013
Q4 2012 61.1 Dec 31, 2012
Q3 2012 56.9 Sep 30, 2012
Q2 2012 50 Jun 30, 2012
Q1 2012 49.3 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.